摘要
我国胃癌发病人数居全球首位,尽管我国胃癌的综合诊治水平已有了巨大的进步,但治疗后的5年总体生存率却仍然处于较低水平。这与我国胃癌早期检出率低、进展期胃癌为主要诊疗对象的模式相关。胃癌的治疗已经进入到分期为导向的生物医学模式,构建在完善全面的分期诊断体系之上的规范化治疗是有效提高我国胃癌诊疗水平的关键,而如何通过多学科协作(MDT)来规范胃癌的临床诊治,以及在临床实践中开展个体化诊疗将是摆在我们面前的重要问题。
The population of patients with gastric cancer （GC） in China ranks first in the world. Although diagnosis and treatment of GC in China have made great progress, the 5-year overall survival rate is still low. With a low rate of early cancer diagnosis, the majority of patients with GC in China have not received optimal treatment before the development of advanced GC, which is believed to be one of the reasons of the low survival rate. The treatment of GC has been converted to a stage-oriented biomedical model. Standardized treatment which is based on a proper staging diagnosis system, which is the key to improve the diagnosis and treatment of GC in China. How to standardize the diagnosis and treatment of GC by a multidiscipinary team, as well as implement individualized diagnosis and treatment in clinical practice would be an important issue for the oncologist in the future.
出处
《中华普外科手术学杂志（电子版）》
2013年第1期1-3,共3页
Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
基金
国家十二五支撑计划项目子课题(2011BAZ03191)
十二五重大专项(2011ZX09307-001-05)
关键词
胃肿瘤
肿瘤治疗方案
Stomach neoplasms
Aatineoplastic protocols
